198 related articles for article (PubMed ID: 35891332)
1. The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication.
Policastro LR; Dolci I; Godoy AS; Silva Júnior JVJ; Ruiz UEA; Santos IA; Jardim ACG; Samby K; Burrows JN; Wells TNC; Gil LHVG; Oliva G; Fernandes RS
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891332
[TBL] [Abstract][Full Text] [Related]
2. In vitro antiviral activity of piperidine alkaloids from Senna spectabilis flowers on Chikungunya virus infection.
Freitas TR; Novais RM; Santos IA; Martins DOS; Danuello A; da Silva Bolzani V; Jardim ACG; Pivatto M
Pharmacol Rep; 2022 Aug; 74(4):752-758. PubMed ID: 35882766
[TBL] [Abstract][Full Text] [Related]
3. Identification of the corticotropin-releasing factor receptor 1 antagonists as inhibitors of Chikungunya virus replication using a Gaussia luciferase-expressing subgenomic replicon.
Watanabe Y; Suzuki Y; Emi A; Murakawa T; Hishiki T; Kato F; Sakaguchi S; Wu H; Yano T; Lim CK; Takasaki T; Nakano T
Biochem Biophys Res Commun; 2022 Dec; 637():181-188. PubMed ID: 36403481
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
mBio; 2016 May; 7(3):. PubMed ID: 27222471
[TBL] [Abstract][Full Text] [Related]
5. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
Akhrymuk I; Lukash T; Frolov I; Frolova EI
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate.
Freire MCLC; Basso LGM; Mendes LFS; Mesquita NCMR; Mottin M; Fernandes RS; Policastro LR; Godoy AS; Santos IA; Ruiz UEA; Caruso IP; Sousa BKP; Jardim ACG; Almeida FCL; Gil LHVG; Andrade CH; Oliva G
Sci Rep; 2022 Jun; 12(1):10601. PubMed ID: 35732685
[TBL] [Abstract][Full Text] [Related]
7. Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathways.
Ruiz UEA; Santos IA; Grosche VR; Fernandes RS; de Godoy AS; Torres JDA; Freire MCLC; Mesquita NCMR; Guevara-Vega M; Nicolau-Junior N; Sabino-Silva R; Mineo TWP; Oliva G; Jardim ACG
Virus Res; 2023 Jan; 324():199029. PubMed ID: 36565816
[TBL] [Abstract][Full Text] [Related]
8. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.
Delang L; Segura Guerrero N; Tas A; Quérat G; Pastorino B; Froeyen M; Dallmeier K; Jochmans D; Herdewijn P; Bello F; Snijder EJ; de Lamballerie X; Martina B; Neyts J; van Hemert MJ; Leyssen P
J Antimicrob Chemother; 2014 Oct; 69(10):2770-84. PubMed ID: 24951535
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
Kaur P; Thiruchelvan M; Lee RC; Chen H; Chen KC; Ng ML; Chu JJ
Antimicrob Agents Chemother; 2013 Jan; 57(1):155-67. PubMed ID: 23275491
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of silymarin against chikungunya virus.
Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
[TBL] [Abstract][Full Text] [Related]
12. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.
Pohjala L; Utt A; Varjak M; Lulla A; Merits A; Ahola T; Tammela P
PLoS One; 2011; 6(12):e28923. PubMed ID: 22205980
[TBL] [Abstract][Full Text] [Related]
15. The Host DHX9 DExH-Box Helicase Is Recruited to Chikungunya Virus Replication Complexes for Optimal Genomic RNA Translation.
Matkovic R; Bernard E; Fontanel S; Eldin P; Chazal N; Hassan Hersi D; Merits A; Péloponèse JM; Briant L
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463980
[TBL] [Abstract][Full Text] [Related]
16. Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication.
Scholte FE; Tas A; Albulescu IC; Žusinaite E; Merits A; Snijder EJ; van Hemert MJ
J Virol; 2015 Apr; 89(8):4457-69. PubMed ID: 25653451
[TBL] [Abstract][Full Text] [Related]
17. Memantine hydrochloride: a drug to be repurposed against Chikungunya virus?
Pereira AKDS; Santos IA; da Silva WW; Nogueira FAR; Bergamini FRG; Jardim ACG; Corbi PP
Pharmacol Rep; 2021 Jun; 73(3):954-961. PubMed ID: 33523405
[TBL] [Abstract][Full Text] [Related]
18. Plants extracts from Cameroon pharmacopeia strongly inhibit the Chikungunya virus infection by targeting entry and replication steps.
Simo Nemg FB; De S; Keshry SS; Mamidi P; Njayou FN; Demanou M; Moundipa Fewou P; Chattopadhyay S
J Ethnopharmacol; 2022 Oct; 296():115458. PubMed ID: 35728708
[TBL] [Abstract][Full Text] [Related]
19. Beyond Members of the
Ferreira AC; Reis PA; de Freitas CS; Sacramento CQ; Villas Bôas Hoelz L; Bastos MM; Mattos M; Rocha N; Gomes de Azevedo Quintanilha I; da Silva Gouveia Pedrosa C; Rocha Quintino Souza L; Correia Loiola E; Trindade P; Rangel Vieira Y; Barbosa-Lima G; de Castro Faria Neto HC; Boechat N; Rehen SK; Brüning K; Bozza FA; Bozza PT; Souza TML
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455237
[TBL] [Abstract][Full Text] [Related]
20. Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery.
Abdelnabi R; Kovacikova K; Moesslacher J; Donckers K; Battisti V; Leyssen P; Langer T; Puerstinger G; Quérat G; Li C; Decroly E; Tas A; Marchand A; Chaltin P; Coutard B; van Hemert M; Neyts J; Delang L
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
